Skip to main content
Filing year 2024

THE MARK FOUNDATION FOR CANCER RESEARCH

New York, New York·EIN 36-4825921·NTEE G30 · Diseases, Disorders & Medical Disciplines·3
Total revenue
$44.8M
Total assets
$105.5M
Total expenses
$0
Reported officers
14
Mission

PARTNER WITH SCIENTISTS TO ACCELERATE RESEARCH THAT WILL TRANSFORM THE PREVENTION, DIAGNOSIS, AND TREATMENT OF CANCER THROUGH GROUND BREAKING SCIENCE CARRIED OUT BY INDIVIDUAL INVESTIGATORS, MULTIDISCIPLINARY TEAMS, AND EARLY STAGE COMPANIES IN THE U.S AND ABROAD.

Executive compensation, broken down

Form 990 · Schedule J · 10 reported individuals · Filing year 2024

Base salaryBonusOther compensationBenefits
Base salaryBonusOther compensationBenefitsExecutive compensation
Chief Executive Officer
$561k
Executive Chairman of the Board
board chair
$560k
Head Discovery/pre-clinical Research
highest compensated employee
$362k
Principal, Venture Investments
key employee
$349k
Head of Development
highest compensated employee
$247k
Director, Grants Administration
highest compensated employee
$232k
Senior Scientific Director
highest compensated employee
$223k
Director Finance & Administration
$216k
Associate Scientific Director
highest compensated employee
$190k
Director
board member
$10k

Plus 4 unpaid individuals.

Browse compensation in Diseases, Disorders & Medical Disciplines

Held steady
from 2023

From $560k in 2023 to $561k in 2024.

$560k
2023
$561k
2024
Highest reported compensation in each year. Volunteer board members and partial-year payouts are filtered out.

Among peers

Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.

Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Create free account
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.